Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis.

Endocr Metab Immune Disord Drug Targets

Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China.

Published: September 2022

N6-methyladenosine (m6A) is a prevalent modification of RNA in eukaryotes, bacteria, and viruses. It is highly conserved and can affect the structure, localization, and biology functions of RNA. In recent years, multiple m6A methylation sites have been identified in the viral RNA genome and transcripts of DNA viruses. This modification occurs commonly during the primary infection and is dynamically regulated by a methyltransferase (writers), demethylase (eraser) and m6A-binding proteins (readers) within the host cells. The abnormal m6A modification not only affects the replication of pathogenic viruses and host immune response but also contributes to the pathogenesis of virus-induced cancers. In this review, we highlight recent advances on the mechanism of m6A modification on viral replication, host immune response and carcinogenesis to provide a novel insight for epigenetic prevention of viral infection and virus-driven carcinogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.2174/2772432817666220412112759DOI Listing

Publication Analysis

Top Keywords

m6a modification
12
modification viral
8
viral infection
8
infection virus-driven
8
virus-driven carcinogenesis
8
host immune
8
immune response
8
m6a
5
modification
5
pathogenic roles
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!